Ascendis Pharma
ASND
ASND
23 hedge funds and large institutions have $184M invested in Ascendis Pharma in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.61%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
7
Increased
10
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
OrbiMed
New York
|
$29.1M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$45.3M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
$23.4M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
$3.47M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
$9.89M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Lazard Asset Management
New York
| – | -$3.58M | -193,050 | Closed |
|
|
PAMU
27
Pictet Asset Management (UK)
London,
United Kingdom
| – | -$540K | -31,100 | Closed |
|
|
SAM
28
Sectoral Asset Management
Montreal,
Quebec, Canada
| – | -$577K | -31,100 | Closed |
|
|
AA
29
ALPS Advisors
Denver,
Colorado
| – | -$524K | -28,259 | Closed |
|
30
Morgan Stanley
New York
| – | -$478K | -25,759 | Closed |
|
31
UBS Group
Zurich,
Switzerland
| – | -$26K | -1,417 | Closed |
|
32
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | -79 | Closed |
|
33
Citigroup
New York
| – | -$1K | -50 | Closed |
|